BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

Free Newsletters
My Subscriptions

News by Subject
News by Disease
News by Date
Search News
Post Your News

Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Pharm Country
  Bio NC
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™


Company Profiles

Research Store

Research Events
Post an Event
Real Estate
Business Opportunities

PLoS By Category | Recent PLoS Articles
Physiology - Urology

Acid Sphingomyelinase Gene Knockout Ameliorates Hyperhomocysteinemic Glomerular Injury in Mice Lacking Cystathionine-ß-Synthase
Published: Friday, September 14, 2012
Author: Krishna M. Boini et al.

by Krishna M. Boini, Min Xia, Justine M. Abais, Ming Xu, Cai-xia Li, Pin-Lan Li

Acid sphingomyelinase (ASM) has been implicated in the development of hyperhomocysteinemia (hHcys)-induced glomerular oxidative stress and injury. However, it remains unknown whether genetically engineering of ASM gene produces beneficial or detrimental action on hHcys-induced glomerular injury. The present study generated and characterized the mice lacking cystathionine ß-synthase (Cbs) and Asm mouse gene by cross breeding Cbs+/- and Asm+/- mice. Given that the homozygotes of Cbs-/-/Asm-/- mice could not survive for 3 weeks. Cbs+/-/Asm+/+, Cbs+/-/Asm+/- and Cbs+/-/Asm-/- as well as their Cbs wild type littermates were used to study the role of Asm-/- under a background of Cbs+/- with hHcys. HPLC analysis revealed that plasma Hcys level was significantly elevated in Cbs heterozygous (Cbs+/-) mice with different copies of Asm gene compared to Cbs+/+ mice with different Asm gene copies. Cbs+/-/Asm+/+ mice had significantly increased renal Asm activity, ceramide production and O2.- level compared to Cbs+/+/Asm+/+, while Cbs+/-/Asm-/- mice showed significantly reduced renal Asm activity, ceramide production and O2.- level due to increased plasma Hcys levels. Confocal microscopy demonstrated that colocalization of podocin with ceramide was much lower in Cbs+/-/Asm-/- mice compared to Cbs+/-/Asm+/+ mice, which was accompanied by a reduced glomerular damage index, albuminuria and proteinuria in Cbs+/-/Asm-/- mice. Immunofluorescent analyses of the podocin, nephrin and desmin expression also illustrated less podocyte damages in the glomeruli from Cbs+/-/Asm-/- mice compared to Cbs+/-/Asm+/+ mice. In in vitro studies of podocytes, hHcys-enhanced O2.- production, desmin expression, and ceramide production as well as decreases in VEGF level and podocin expression in podocytes were substantially attenuated by prior treatment with amitriptyline, an Asm inhibitor. In conclusion, Asm gene knockout or corresponding enzyme inhibition protects the podocytes and glomeruli from hHcys-induced oxidative stress and injury.